Paladin, overexpressed in colon cancer, is required for actin polymerisation and liver metastasis dissemination

• Published in: Oncogenesis (New York, NY) NY), 2022-07, Vol.11 (1), p.42-42, Article 42
• Main Authors: Rademaker, Gilles, Costanza, Brunella, Pyr dit Ruys, Sébastien, Peiffer, Raphaël, Agirman, Ferman, Maloujahmoum, Naïma, Vertommen, Didier, Turtoi, Andrei, Bellahcène, Akeila, Castronovo, Vincent, Peulen, Olivier
• Format: Article
• Language: English
• Subjects: 38/89; 59/5; 631/67/1504/1885; 631/67/322; 631/80/128; 631/80/84; 64/60; 82/1; 82/58; 82/80; Actin; Apoptosis; Biochemistry, biophysics & molecular biology; Biochimie, biophysique & biologie moléculaire; Biomarkers; Cell adhesion & migration; Cell Biology; Cell migration; Colon cancer; Colorectal cancer; Colorectal carcinoma; Cytoskeleton; Human Genetics; Human health sciences; Immunoprecipitation; Internal Medicine; Life sciences; Liver cancer; Medicine; Medicine & Public Health; Metastases; Metastasis; Oncologie; Oncology; Paladin; PALD1; Proteomes; Public health; Sciences de la santé humaine; Sciences du vivant
• ISSN: 2157-9024; 2157-9024
• DOI: 10.1038/s41389-022-00416-4

Introduction Colorectal cancer remains a public health issue and most colon cancer patients succumb to the development of metastases. Using a specific protocol of pressure-assisted interstitial fluid extrusion to recover soluble biomarkers, we identified paladin as a potential colon cancer liver metastases biomarker. Methods Using shRNA gene knockdown, we explored the biological function of paladin in colon cancer cells and investigated the phospho-proteome within colon cancer cells. We successively applied in vitro migration assays, in vivo metastasis models and co-immunoprecipitation experiments. Results We discovered that paladin is required for colon cancer cell migration and metastasis, and that paladin depletion altered the phospho-proteome within colon cancer cells. Data are available via ProteomeXchange with identifier PXD030803. Thanks to immunoprecipitation experiments, we demonstrated that paladin, was interacting with SSH1, a phosphatase involved in colon cancer metastasis. Finally, we showed that paladin depletion in cancer cells results in a less dynamic actin cytoskeleton. Conclusions Paladin is an undervalued protein in oncology. This study highlights for the first time that, paladin is participating in actin cytoskeleton remodelling and is required for efficient cancer cell migration.